US Acoustic Neuroma Market

ID: MRFR/MED/17442-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026
US Acoustic Neuroma Market Research Report By Type (unilateral vestibular schwannomas, bilateral vestibular schwannomas), By Diagnosis (hearing test (audiometry), electronystagmography, magnetic resonance imaging (MRI), others), By Drug Class (anticonvulsants, corticosteroids, osmotic diuretics, pain killers), By Treatment (monitoring, surgery, radiation therapy, supportive therapy, others, stereotactic radiotherapy, proton beam therapy, radiosurgery, craniotomy, microsurgery removal) and By End User (hospitals, diagnostic centers, academic and research institutes, others) - Growth & Industry Forecast 2025 To 2035
US Acoustic Neuroma Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.43%
2024 Market Size$ 500.09 Million
2025 Market Size$ 537.25 Million
2035 Market Size$ 1,100.09 Million
Key Players
Medtronic
Stryker
Johnson & Johnson
Boston Scientific
Cochlear
Siemens Healthineers
Trends
  • Technological Advancements in Treatment
  • Increased Patient Awareness and Advocacy
  • Integration of Telemedicine
Opportunities
  • Advancements in Surgical Techniques
  • Rising Incidence of Acoustic Neuroma Cases
  • Growing Investment in Research and Development
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Medical Device, BY Type (USD Million)
      1. 4.1.1 Unilateral Vestibular Schwannomas
      2. 4.1.2 Bilateral Vestibular Schwannomas
    2. 4.2 Medical Device, BY Diagnosis (USD Million)
      1. 4.2.1 Hearing Test (Audiometry)
      2. 4.2.2 Electronystagmography
      3. 4.2.3 Magnetic Resonance Imaging (MRI)
      4. 4.2.4 Others
    3. 4.3 Medical Device, BY Drug Class (USD Million)
      1. 4.3.1 Anticonvulsants
      2. 4.3.2 Corticosteroids
      3. 4.3.3 Osmotic Diuretics
      4. 4.3.4 Pain Killers
    4. 4.4 Medical Device, BY Treatment (USD Million)
      1. 4.4.1 Monitoring
      2. 4.4.2 Surgery
      3. 4.4.3 Radiation Therapy
      4. 4.4.4 Supportive Therapy
      5. 4.4.5 Others
    5. 4.5 Medical Device, BY End-User (USD Million)
      1. 4.5.1 Hospitals
      2. 4.5.2 Diagnostic Centers
      3. 4.5.3 Academic and Research Institutes
      4. 4.5.4 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Medical Device
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Stryker (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Johnson & Johnson (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Boston Scientific (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Cochlear (AU)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Siemens Healthineers (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Abbott Laboratories (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 NeuroPace (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TYPE
    3. 6.3 US MARKET ANALYSIS BY DIAGNOSIS
    4. 6.4 US MARKET ANALYSIS BY DRUG CLASS
    5. 6.5 US MARKET ANALYSIS BY TREATMENT
    6. 6.6 US MARKET ANALYSIS BY END-USER
    7. 6.7 KEY BUYING CRITERIA OF MEDICAL DEVICE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF MEDICAL DEVICE
    10. 6.10 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
    12. 6.12 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
    13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
    14. 6.14 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
    15. 6.15 MEDICAL DEVICE, BY DIAGNOSIS, 2024 (% SHARE)
    16. 6.16 MEDICAL DEVICE, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
    17. 6.17 MEDICAL DEVICE, BY DRUG CLASS, 2024 (% SHARE)
    18. 6.18 MEDICAL DEVICE, BY DRUG CLASS, 2024 TO 2035 (USD Million)
    19. 6.19 MEDICAL DEVICE, BY TREATMENT, 2024 (% SHARE)
    20. 6.20 MEDICAL DEVICE, BY TREATMENT, 2024 TO 2035 (USD Million)
    21. 6.21 MEDICAL DEVICE, BY END-USER, 2024 (% SHARE)
    22. 6.22 MEDICAL DEVICE, BY END-USER, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY DIAGNOSIS, 2025-2035 (USD Million)
      3. 7.2.3 BY DRUG CLASS, 2025-2035 (USD Million)
      4. 7.2.4 BY TREATMENT, 2025-2035 (USD Million)
      5. 7.2.5 BY END-USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US US Acoustic Neuroma Market Segmentation

US Acoustic Neuroma Market By Type (USD Million, 2025-2035)

  • Unilateral Vestibular Schwannomas
  • Bilateral Vestibular Schwannomas

US Acoustic Neuroma Market By Diagnosis (USD Million, 2025-2035)

  • Hearing Test (Audiometry)
  • Electronystagmography
  • Magnetic Resonance Imaging (MRI)
  • Others

US Acoustic Neuroma Market By Drug Class (USD Million, 2025-2035)

  • Anticonvulsants
  • Corticosteroids
  • Osmotic Diuretics
  • Pain Killers

US Acoustic Neuroma Market By Treatment (USD Million, 2025-2035)

  • Monitoring
  • Surgery
  • Radiation Therapy
  • Supportive Therapy
  • Others

US Acoustic Neuroma Market By End-User (USD Million, 2025-2035)

  • Hospitals
  • Diagnostic Centers
  • Academic and Research Institutes
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.